Citations (144)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Lan Sun, Hong-Juan Yao, Jing-Cao Li, Bao-Quan Zhao, Yong-An Wang & Ying-Ge Zhang. (2023) Activated Carbon nanoparticles Loaded with Metformin for Effective Against Hepatocellular Cancer Stem Cells. International Journal of Nanomedicine 18, pages 2891-2910.
Read now
Read now
A. Keshandehghan, S. Nikkhah, H. Tahermansouri, S. Heidari-Keshel & M. Gardaneh. (2020) Co-Treatment with Sulforaphane and Nano-Metformin Molecules Accelerates Apoptosis in HER2+ Breast Cancer Cells by Inhibiting Key Molecules. Nutrition and Cancer 72:5, pages 835-848.
Read now
Read now
Julianna M. Santos & Fazle Hussain. (2020) Higher Glucose Enhances Breast Cancer Cell Aggressiveness. Nutrition and Cancer 72:5, pages 734-746.
Read now
Read now
Anne-Sophie Hamy, Lisa Derosa, Constance Valdelièvre, Satoru Yonekura, Paule Opolon, Maël Priour, Julien Guerin, Jean-Yves Pierga, Bernard Asselain, Diane De Croze, Alice Pinheiro, Marick Lae, Laure-Sophie Talagrand, Enora Laas, Lauren Darrigues, Beatriz Grandal, Elisabetta Marangoni, Elodie Montaudon, Guido Kroemer, Laurence Zitvogel & Fabien Reyal. (2020) Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer. OncoImmunology 9:1.
Read now
Read now
Elisabet Cuyàs, Begoña Martin-Castillo, Joaquim Bosch-Barrera & Javier A. Menendez. (2017) Metformin inhibits RANKL and sensitizes cancer stem cells to denosumab. Cell Cycle 16:11, pages 1022-1028.
Read now
Read now
Corinna Seliger, Anne-Louise Meyer, Kathrin Renner, Verena Leidgens, Sylvia Moeckel, Birgit Jachnik, Katja Dettmer, Ulrike Tischler, Valeria Gerthofer, Lisa Rauer, Martin Uhl, Martin Proescholdt, Ulrich Bogdahn, Markus J. Riemenschneider, Peter J. Oefner, Marina Kreutz, Arabel Vollmann-Zwerenz & Peter Hau. (2016) Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2. Cell Cycle 15:13, pages 1755-1766.
Read now
Read now
Reema Wahdan-Alaswad, Zeying Fan, Susan M Edgerton, Bolin Liu, Xin-Sheng Deng, Sigrid Salling Arnadottir, Jennifer K Richer, Steven M Anderson & Ann D Thor. (2013) Glucose promotes breast cancer aggression and reduces metformin efficacy. Cell Cycle 12:24, pages 3759-3769.
Read now
Read now
JAVIER MENENDEZ, Jorge Joven, SÍLVIA CUFÍ, BRUNA COROMINAS-FAJA, Cristina Oliveras-Ferraros, ELISABET CUYÀS, Begoña Martin-Castillo, Eugeni López-Bonet, TOMÁS ALARCÓN & Alejandro Vazquez-Martin. (2013) The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells. Cell Cycle 12:8, pages 1166-1179.
Read now
Read now
Begoña Martin-Castillo, Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Silvia Cufí, José Manuel Moreno, Bruna Corominas-Faja, Ander Urruticoechea, Ángel G. Martín, Eugeni López-Bonet & Javier A. Menendez. (2013) Basal/HER2 breast carcinomas. Cell Cycle 12:2, pages 225-245.
Read now
Read now
William H. Chappell, Stephen L. Abrams, Richard A. Franklin, Michelle M. LaHair, Giuseppe Montalto, Melchiorre Cervello, Alberto M. Martelli, Ferdinando Nicoletti, Saverio Candido, Massimo Libra, Jerry Polesel, Renato Talamini, Michele Milella, Agostino Tafuri, Linda S. Steelman & James A. McCubrey. (2012) Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine. Cell Cycle 11:23, pages 4447-4461.
Read now
Read now
Cristina Oliveras-Ferraros, Bruna Corominas-Faja, Sílvia Cufí, Alejandro Vazquez-Martin, Begoña Martin-Castillo, Juan Manuel Iglesias, Eugeni López-Bonet, Ángel G. Martin & Javier A. Menendez. (2012) Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). Cell Cycle 11:21, pages 4020-4032.
Read now
Read now
Ashwani Khurana & Viji Shridhar. (2012) Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle 11:15, pages 2779-2779.
Read now
Read now
Javier A. Menendez, Cristina Oliveras-Ferraros, Sílvia Cufí, BRUNA COROMINAS-FAJA, Jorge Joven, Begoña Martin-Castillo & Alejandro Vazquez-Martin. (2012) Metformin is synthetically lethal with glucose withdrawal in cancer cells. Cell Cycle 11:15, pages 2782-2792.
Read now
Read now
Francesca Ricci, Sergio Bernasconi, Patrizia Perego, Monica Ganzinelli, Giorgio Russo, Francesca Bono, Costantino Mangioni, Robert Fruscio, Mario Signorelli, Massimo Broggini & Giovanna Damia. (2012) Ovarian carcinoma tumor-initiating cells have a mesenchymal phenotype. Cell Cycle 11:10, pages 1966-1976.
Read now
Read now
Alejandro Vazquez-Martin, Luciano Vellon, Pedro M. Quirós, Sílvia Cufí, Eunate Ruiz de Galarreta, Cristina Oliveras-Ferraros, Angel G. Martin, Begoña Martin-Castillo, Carlos López-Otín & Javier A. Menendez. (2012) Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells. Cell Cycle 11:5, pages 974-989.
Read now
Read now
Diana Whitaker-Menezes, Ubaldo E. Martinez-Outschoorn, Neal Flomenberg, Ruth Birbe, Agnieszka K. Witkiewicz, Anthony Howell, Stephanos Pavlides, Aristotelis Tsirigos, Adam Ertel, Richard G. Pestell, Paolo Broda, Carlo Minetti, Michael P. Lisanti & Federica Sotgia. (2011) Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ. Cell Cycle 10:23, pages 4047-4064.
Read now
Read now
Ubaldo E. Martinez-Outschoorn, Marco Prisco, Adam Ertel, Aristotelis Tsirigos, Zhao Lin, Stephanos Pavlides, Chengwang Wang, Neal Flomenberg, Erik S. Knudsen, Anthony Howell, Richard G. Pestell, Federica Sotgia & Michael P Lisanti. (2011) Ketones and lactate increase cancer cell “stemness,” driving recurrence, metastasis and poor clinical outcome in breast cancer. Cell Cycle 10:8, pages 1271-1286.
Read now
Read now
Articles from other publishers (127)
Jiali Yang, Juan Liu, Jiayu Liang, Fan Li, Wenwen Wang, Huan Chen & Xiang Xie. (2023) Epithelial-mesenchymal transition in age-associated thymic involution: Mechanisms and therapeutic implications. Ageing Research Reviews 92, pages 102115.
Crossref
Crossref
Rishabha Malviya, Arun Kumar Singh & Deepika YadavRishabha Malviya, Arun Kumar Singh & Deepika Yadav. 2023. Multi‐Drug Resistance in Cancer. Multi‐Drug Resistance in Cancer
131
153
.
Akshay S. Kulkarni, Anshurekha Dash, Rahul D. Shingare, Jagdish Chand, Diksha Manhas, Aman Singh, Utpal Nandi, Anindya Goswami & D. Srinivasa Reddy. (2023) Identification of new modulator of DNA repairing pathways based on natural product (±)-peharmaline A. Bioorganic & Medicinal Chemistry 91, pages 117365.
Crossref
Crossref
Ayesha Siddika, Md. Nurujjaman, Abdul Auwal, Tasfik Ul Haque Pronoy & Farhadul Islam. 2023. Cancer Stem Cells: Basic Concept and Therapeutic Implications. Cancer Stem Cells: Basic Concept and Therapeutic Implications
83
100
.
Lili Qiao, Yanfei Chen, Ning Liang, Jian Xie, Guodong Deng, Fangjie Chen, Xiaojuan Wang, Fengjun Liu, Yupeng Li & Jiandong Zhang. (2022) Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies. Frontiers in Oncology 12.
Crossref
Crossref
Shruthi Suthakaran, Digvijay Singh, Rohit K. Deshmukh & Amitava Das. 2022. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
2539
2563
.
Shruthi Suthakaran, Digvijay Singh, Rohit K. Deshmukh & Amitava Das. 2021. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects. Handbook of Oxidative Stress in Cancer: Therapeutic Aspects
1
25
.
Oleksandr Grytsai, Iuliia Myrgorodska, Stéphane Rocchi, Cyril Ronco & Rachid Benhida. (2021) Biguanides drugs: Past success stories and promising future for drug discovery. European Journal of Medicinal Chemistry 224, pages 113726.
Crossref
Crossref
Ya Cao, Xiaomeng Yu, Bing Han, Langjian Dong, Jingjing Xu, Yuhao Dai, Genxi Li & Jing Zhao. (2021) In Situ Programmable DNA Circuit-Promoted Electrochemical Characterization of Stemlike Phenotype in Breast Cancer. Journal of the American Chemical Society 143:39, pages 16078-16086.
Crossref
Crossref
Hiroyuki Tsuchiya & Goshi Shiota. (2021) Immune evasion by cancer stem cells. Regenerative Therapy 17, pages 20-33.
Crossref
Crossref
Mahsa Golshan, Saeedeh Khaleghi, Sayed Mohammad Shafiee, Shiva Valaee, Zahra Ghanei, Abbas Jamshidizad, Mojtaba Dashtizad & Mehdi Shamsara. (2020) Metformin modulates oncogenic expression of HOTAIR gene via promoter methylation and reverses epithelial–mesenchymal transition in MDA‐MB‐231 cells. Journal of Cellular Biochemistry 122:3-4, pages 385-393.
Crossref
Crossref
Marissa LoblMadison GrinnellAndrew Phillips, Joshua AbelsAshley Wysong. (2021) The Correlation Between Immunohistochemistry Findings and Metastasis in Squamous Cell Carcinoma: A Review. Dermatologic Surgery 47:3, pages 313-318.
Crossref
Crossref
Plabon Kumar Das, Farhadul Islam, Robert A. Smith & Alfred K. Lam. (2021) Therapeutic Strategies Against Cancer Stem Cells in Esophageal Carcinomas. Frontiers in Oncology 10.
Crossref
Crossref
Yangfan Liu, Miao Yang, Jingjing Luo & Hongmei Zhou. (2020) Radiotherapy targeting cancer stem cells “awakens” them to induce tumour relapse and metastasis in oral cancer. International Journal of Oral Science 12:1.
Crossref
Crossref
Nuray Erin, Jelena Grahovac, Anamaria Brozovic & Thomas Efferth. (2020) Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance. Drug Resistance Updates 53, pages 100715.
Crossref
Crossref
Tasnim Zahan, Plabon K. Das, Syeda F. Akter, Rowshanul Habib, Md. Habibur Rahman, Md. Rezaul Karim & Farhadul Islam. (2020) Therapy Resistance in Cancers: Phenotypic, Metabolic, Epigenetic and Tumour Microenvironmental Perspectives. Anti-Cancer Agents in Medicinal Chemistry 20:18, pages 2190-2206.
Crossref
Crossref
Samson Mathews Samuel, Elizabeth Varghese, Lenka Koklesová, Alena Líšková, Peter Kubatka & Dietrich Büsselberg. (2020) Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells. Cancers 12:9, pages 2482.
Crossref
Crossref
Alex J. Gooding & William P. Schiemann. (2020) Epithelial–Mesenchymal Transition Programs and Cancer Stem Cell Phenotypes: Mediators of Breast Cancer Therapy Resistance. Molecular Cancer Research 18:9, pages 1257-1270.
Crossref
Crossref
Xu Zhang, Fei Wang, Yu Zeng, Xuyou Zhu, Lin Peng, Long Zhang, Jun Gu, Hongxiu Han, Xianghua Yi & Juanhong Shi. (2020) Salicylate sensitizes oral squamous cell carcinoma to chemotherapy through targeting mTOR pathway. Oral Diseases 26:6, pages 1131-1140.
Crossref
Crossref
Jelena Dinić, Thomas Efferth, Alfonso T. García-Sosa, Jelena Grahovac, José M. Padrón, Ilza Pajeva, Flavio Rizzolio, Simona Saponara, Gabriella Spengler & Ivanka Tsakovska. (2020) Repurposing old drugs to fight multidrug resistant cancers. Drug Resistance Updates 52, pages 100713.
Crossref
Crossref
Elham Amjad, Solmaz Asnaashari, Babak Sokouti & Siavoush Dastmalchi. (2020) Systems biology comprehensive analysis on breast cancer for identification of key gene modules and genes associated with TNM-based clinical stages. Scientific Reports 10:1.
Crossref
Crossref
Souneek Chakraborty, Khalid Bashir Mir, Nathan D. Seligson, Debasis Nayak, Rakesh Kumar & Anindya Goswami. (2020) Integration of EMT and cellular survival instincts in reprogramming of programmed cell death to anastasis. Cancer and Metastasis Reviews 39:2, pages 553-566.
Crossref
Crossref
Plabon Kumar Das, Suja Pillai, Md. Abdur Rakib, Jahan Ara Khanam, Vinod Gopalan, Alfred K. Y. Lam & Farhadul Islam. (2020) Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance. Stem Cell Reviews and Reports 16:2, pages 397-412.
Crossref
Crossref
József Dudás, Andrea Ladányi, Julia Ingruber, Teresa Bernadette Steinbichler & Herbert Riechelmann. (2020) Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance. Cells 9:2, pages 428.
Crossref
Crossref
Reema S. Wahdan-Alaswad & Ann D. Thor. 2020. Metformin [Working Title]. Metformin [Working Title].
Masaki Ueno, Manabu Kawai, Jin-Young Park, Seiko Hirono, Ken-ichi Okada, Shinya Hayami, Hee-Jung Wang & Hiroki Yamaue. (2020) Prognostic Analysis of Hepatocellular Carcinoma With Hepatitis C Virus Infection Using Epithelial-Mesenchymal Transition Gene Profiles. Journal of Surgical Research 245, pages 302-308.
Crossref
Crossref
José Esparza-López, Juan Francisco Alvarado-Muñoz, Elizabeth Escobar-Arriaga, Alfredo Ulloa-Aguirre & María de Jesús Ibarra-Sánchez. (2019) Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways. BMC Cancer 19:1.
Crossref
Crossref
Arindam Banerjee, Charles N Birts, Matthew Darley, Rachel Parker, Alex H Mirnezami, Jonathan West, Ramsey I Cutress, Stephen A Beers, Matthew J J Rose-Zerilli & Jeremy P Blaydes. (2019) Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization. Carcinogenesis 40:7, pages 871-882.
Crossref
Crossref
Hidehiro Tajima, Tetsuo Ohta, Mitsuyoshi Okazaki, Takahisa Yamaguchi, Yoshinao Ohbatake, Koichi Okamoto, Shinichi Nakanuma, Jun Kinoshita, Isamu Makino, Keishi Nakamura, Tomoharu Miyashita, Hiroyuki Takamura, Itasu Ninomiya, Sachio Fushida & Hiroyuki Nakamura. (2019) Neoadjuvant chemotherapy with gemcitabine‑based regimens improves the prognosis of node positive resectable pancreatic head cancer. Molecular and Clinical Oncology.
Crossref
Crossref
Petra Jagust, Beatriz de Luxán-Delgado, Beatriz Parejo-Alonso & Patricia Sancho. (2019) Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells. Frontiers in Pharmacology 10.
Crossref
Crossref
Federica Barbieri, Ivan Verduci, Valentina Carlini, Gianluigi Zona, Aldo Pagano, Michele Mazzanti & Tullio Florio. (2019) Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity. Frontiers in Oncology 9.
Crossref
Crossref
Ankit Sharma, Shreetama Bandyopadhayaya, Kaushik Chowdhury, Tanu Sharma, Rekha Maheshwari, Amlan Das, Gopal Chakrabarti, Vipin Kumar & Chandi C. Mandal. (2019) Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells. PLOS ONE 14:1, pages e0209435.
Crossref
Crossref
Olivera Bozickovic, Linn Skartveit, Agnete S.T. Engelsen, Thomas Helland, Kristin Jonsdottir, Marianne Hauglid Flågeng, Ingvild S. Fenne, Emiel Janssen, James B. Lorens, Lise Bjørkhaug, Jørn V. Sagen & Gunnar Mellgren. (2019) A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 185, pages 57-70.
Crossref
Crossref
Yun‑Suk Kwon, So‑Young Chun, Hong‑Yan Nan, Kyung‑Soo Nam, Chuhee Lee & Soyoung Kim. (2018) Metformin selectively targets 4T1 tumorspheres and enhances the antitumor effects of doxorubicin by downregulating the AKT and STAT3 signaling pathways. Oncology Letters.
Crossref
Crossref
Stephan Marquardt, Manish Solanki, Alf Spitschak, Julio Vera & Brigitte M. Pützer. (2018) Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Seminars in Cancer Biology 53, pages 90-109.
Crossref
Crossref
Sanghee Kang, Bo Ram Kim, Myoung-Hee Kang, Dae-Young Kim, Dae-Hee Lee, Sang Cheul Oh, Byung Wook Min & Jun Won Um. (2018) Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial–mesenchymal transition in human colon cancer cells. PLOS ONE 13:10, pages e0205449.
Crossref
Crossref
Yaodu Wang, Zhiyang Wu & Likuan Hu. (2018) The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC). European Journal of Pharmacology 834, pages 45-53.
Crossref
Crossref
Manish Chand, Deborah S Keller, Reza Mirnezami, Marc Bullock, Aneel Bhangu, Brendan Moran, Paris P Tekkis, Gina Brown, Alex Mirnezami & Mariana Berho. (2018) Novel biomarkers for patient stratification in colorectal cancer: A review of definitions, emerging concepts, and data. World Journal of Gastrointestinal Oncology 10:7, pages 145-158.
Crossref
Crossref
Vusala Snyder, Tamika C. Reed-Newman, Levi Arnold, Sufi Mary Thomas & Shrikant Anant. (2018) Cancer Stem Cell Metabolism and Potential Therapeutic Targets. Frontiers in Oncology 8.
Crossref
Crossref
Andréia Vasconcelos-dos-Santos, Rafaela Muniz de Queiroz, Bruno da Costa Rodrigues, Adriane R. Todeschini & Wagner B. Dias. (2018) Hyperglycemia and aberrant O-GlcNAcylation: contributions to tumor progression. Journal of Bioenergetics and Biomembranes 50:3, pages 175-187.
Crossref
Crossref
Jiayu Gao, Jinhui Ye, Ying Ying, Hui Lin & Zhijun Luo. (2018) Negative regulation of TGF-β by AMPK and implications in the treatment of associated disorders. Acta Biochimica et Biophysica Sinica 50:6, pages 523-531.
Crossref
Crossref
Nipun Saini & Xiaohe Yang. (2018) Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells. Acta Biochimica et Biophysica Sinica 50:2, pages 133-143.
Crossref
Crossref
E Cuyàs, S Fernández-Arroyo, S Verdura, R Á-F García, J Stursa, L Werner, E Blanco-González, M Montes-Bayón, J Joven, B Viollet, J Neuzil & J A Menendez. (2017) Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism. Oncogene 37:7, pages 963-970.
Crossref
Crossref
Magdalena Szaryńska, Agata Olejniczak, Jarosław Kobiela, Piotr Spychalski & Zbigniew Kmieć. (2017) Therapeutic strategies against cancer stem cells in human colorectal cancer (Review). Oncology Letters.
Crossref
Crossref
Sugandha Bhatia, James Monkman, Alan Kie Leong Toh, Shivashankar H. Nagaraj & Erik W. Thompson. (2017) Targeting epithelial–mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring. Biochemical Journal 474:19, pages 3269-3306.
Crossref
Crossref
Brigitte M. Pützer, Manish Solanki & Ottmar Herchenröder. (2017) Advances in cancer stem cell targeting: How to strike the evil at its root. Advanced Drug Delivery Reviews 120, pages 89-107.
Crossref
Crossref
Feixue Feng, Jianping Zhang, Xiaoxuan Fan, Fang Yuan, Yinghao Jiang, Ruihua Lv & Yanxia Ma. (2017) Downregulation of Rab27A contributes to metformin-induced suppression of breast cancer stem cells. Oncology Letters 14:3, pages 2947-2953.
Crossref
Crossref
Yan Zhang, Xiuli Feng, Tao Li, Erpan Yi & Yu Li. (2017) Metformin synergistic pemetrexed suppresses non-small-cell lung cancer cell proliferation and invasion in vitro. Cancer Medicine 6:8, pages 1965-1975.
Crossref
Crossref
Hyun-Soo Shin, Jiyeon Ko, Dal-Ah Kim, Eun-Sun Ryu, Hye-Myung Ryu, Sun-Hee Park, Yong-Lim Kim, Eok-Soo Oh & Duk-Hee Kang. (2017) Metformin ameliorates the Phenotype Transition of Peritoneal Mesothelial Cells and Peritoneal Fibrosis via a modulation of Oxidative Stress. Scientific Reports 7:1.
Crossref
Crossref
Hidehiro Tajima, Isamu Makino, Yoshinao Ohbatake, Shinichi Nakanuma, Hironori Hayashi, Hisatoshi Nakagawara, Tomoharu Miyashita, Hiroyuki Takamura & Tetsuo Ohta. (2017) Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives. Oncology Letters 13:6, pages 3975-3981.
Crossref
Crossref
Sebastian Müller, Tatiana Cañeque, Verónica Acevedo & Raphaël Rodriguez. (2017) Targeting Cancer Stem Cells with Small Molecules. Israel Journal of Chemistry 57:3-4, pages 239-250.
Crossref
Crossref
Arja Ray, Zachary M. Slama, Rachel K. Morford, Samantha A. Madden & Paolo P. Provenzano. (2017) Enhanced Directional Migration of Cancer Stem Cells in 3D Aligned Collagen Matrices. Biophysical Journal 112:5, pages 1023-1036.
Crossref
Crossref
So-Young Chun, Soyoung Kim & Kyung-Soo Nam. (2017) The inhibitory effects of deep-sea water on doxorubicin-induced epithelial-mesenchymal transition. Oncology Reports 38:2, pages 1163-1171.
Crossref
Crossref
Xiaowei Jiang, Dan Guo, Wenfang Li, Tianwu Yu, Jian Zhou & Jianping Gong. (2017) Combination Twist1 and CA15-3 in axillary lymph nodes for breast cancer prognosis. Molecular Medicine Reports.
Crossref
Crossref
Akira Nakayama, Itasu Ninomiya, Shinichi Harada, Tomoya Tsukada, Koichi Okamoto, Shinichi Nakanuma, Seisho Sakai, Isamu Makino, Jun Kinoshita, Hironori Hayashi, Katsunobu Oyama, Tomoharu Miyashita, Hidehiro Tajima, Hiroyuki Takamura, Sachio Fushida & Tetsuo Ohta. (2016) Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma. International Journal of Oncology 49:5, pages 1890-1898.
Crossref
Crossref
Archana Bhaw-Luximon & Dhanjay Jhurry. (2016) Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification. Journal of Cancer Research and Clinical Oncology 142:10, pages 2159-2171.
Crossref
Crossref
Ido Laskov, Paul Abou-Nader, Oreekha Amin, Charles-Andre Philip, Marie-Claude Beauchamp, Amber Yasmeen & Walter H. Gotlieb. (2016) Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines. International Journal of Gynecological Cancer 26:7, pages 1213-1221.
Crossref
Crossref
Bowen Du & Joong Shim. (2016) Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules 21:7, pages 965.
Crossref
Crossref
Hui-Hui Zhang & Xiu-Li Guo. (2016) Combinational strategies of metformin and chemotherapy in cancers. Cancer Chemotherapy and Pharmacology 78:1, pages 13-26.
Crossref
Crossref
Patricia Sancho, David Barneda & Christopher Heeschen. (2016) Hallmarks of cancer stem cell metabolism. British Journal of Cancer 114:12, pages 1305-1312.
Crossref
Crossref
STEFAN KOECK, ARNO AMANN, JULIA M. HUBER, GABRIELE GAMERITH, WOLFGANG HILBE & HEINZ ZWIERZINA. (2016) The impact of metformin and salinomycin on transforming growth factor β-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cell lines. Oncology Letters 11:4, pages 2946-2952.
Crossref
Crossref
Michael Karsy, Jian Guan, Randy Jensen, L. Eric Huang & Howard Colman. (2016) The Impact of Hypoxia and Mesenchymal Transition on Glioblastoma Pathogenesis and Cancer Stem Cells Regulation. World Neurosurgery 88, pages 222-236.
Crossref
Crossref
Kyung Don JuHyo Jin KimBodokhsuren TsogbadrakhJinho LeeHyunjin RyuEun Jin ChoYoung-Hwan Hwang, Kiwon Kim, Jaeseok YangCurie AhnKook-Hwan Oh. (2016) HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis. American Journal of Physiology-Renal Physiology 310:5, pages F342-F350.
Crossref
Crossref
F Bost, A-G Decoux-Poullot, J F Tanti & S Clavel. (2016) Energy disruptors: rising stars in anticancer therapy?. Oncogenesis 5:1, pages e188-e188.
Crossref
Crossref
Rosa Lauretta, Giulia Lanzolla, Patrizia Vici, Luciano Mariani, Costanzo Moretti & Marialuisa Appetecchia. (2016) Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk. International Journal of Endocrinology 2016, pages 1-17.
Crossref
Crossref
B.T. Spike. 2016. Cancer Stem Cells. Cancer Stem Cells
121
148
.
Rongrong Zhang, Ping Zhang, Hong Wang, Dongming Hou, Wentao Li, Guishan Xiao & Chenwei Li. (2015) Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44+CD117+ ovarian cancer stem cells. Stem Cell Research & Therapy 6:1.
Crossref
Crossref
Hui Lin, Nianshuang Li, Huan He, Ying Ying, Shashank Sunkara, Lingyu Luo, Nonghua Lv, Deqiang Huang & Zhijun Luo. (2015)
AMPK Inhibits the Stimulatory Effects of TGF-
β
on Smad2/3 Activity, Cell Migration, and Epithelial-to-Mesenchymal Transition
. Molecular Pharmacology 88:6, pages 1062-1071.
Crossref
Crossref
J.A. Jara & R. López-Muñoz. (2015) Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity. Pharmacological Research 101, pages 102-108.
Crossref
Crossref
F. Coperchini, P. Leporati, M. Rotondi & L. Chiovato. (2015) Expanding the therapeutic spectrum of metformin: from diabetes to cancer. Journal of Endocrinological Investigation 38:10, pages 1047-1055.
Crossref
Crossref
K. Saeki, M. Watanabe, M. Tsuboi, S. Sugano, R. Yoshitake, Y. Tanaka, S.M. Ong, T. Saito, K. Matsumoto, N. Fujita, R. Nishimura & T. Nakagawa. (2015) Anti-tumour effect of metformin in canine mammary gland tumour cells. The Veterinary Journal 205:2, pages 297-304.
Crossref
Crossref
Valentina Angeloni, Paola Tiberio, Valentina Appierto & Maria Grazia Daidone. (2015) Implications of stemness-related signaling pathways in breast cancer response to therapy. Seminars in Cancer Biology 31, pages 43-51.
Crossref
Crossref
Jianlin Wang, Xisheng Yang, Bai Ruan, Bin Dai, Yuan Gao, Juanli Duan, Shibin Qu, Kaishan Tao, Kefeng Dou & Haimin Li. (2014) Overexpression of miR-200a suppresses epithelial-mesenchymal transition of liver cancer stem cells. Tumor Biology 36:4, pages 2447-2456.
Crossref
Crossref
Chang-I. Chen, Ching-Feng Kuan, Yu-Ann Fang, Shing-Hwa Liu, Ju-Chi Liu, Li-Li Wu, Chun-Jen Chang, Hsuan-Chia Yang, Jaulang Hwang, James S. Miser & Szu-Yuan Wu. (2015) Cancer Risk in HBV Patients With Statin and Metformin Use. Medicine 94:6, pages e462.
Crossref
Crossref
Mehmet Asim Bilen, Sue-Hwa Lin, Dean G. Tang, Kinjal Parikh, Mong-Hong Lee, Sai-Ching J. Yeung & Shi-Ming Tu. (2015) Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series. Case Reports in Oncological Medicine 2015, pages 1-5.
Crossref
Crossref
Alice Turdo, Matilde Todaro & Giorgio Stassi. 2015. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
445
476
.
Anai N Kothari, Zhiyong Mi, Matthew Zapf & Paul C Kuo. (2014) Novel clinical therapeutics targeting the epithelial to mesenchymal transition. Clinical and Translational Medicine 3:1.
Crossref
Crossref
Maria A Papadaki, Galatea Kallergi, Zafeiris Zafeiriou, Lefteris Manouras, Panayiotis A Theodoropoulos, Dimitris Mavroudis, Vassilis Georgoulias & Sofia Agelaki. (2014) Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer. BMC Cancer 14:1.
Crossref
Crossref
Murielle Mimeault & Surinder K. Batra. (2014) Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies. Molecular Aspects of Medicine 39, pages 3-32.
Crossref
Crossref
Javier A. Menendez & Tomás Alarcón. (2014) Metabostemness: A New Cancer Hallmark. Frontiers in Oncology 4.
Crossref
Crossref
Iuliana Nenu, Tiberiu Popescu, Mihaela D. Aldea, Lucian Craciun, Diana Olteanu, Corina Tatomir, Pompei Bolfa, Rodica M. Ion, Adriana Muresan & Adriana G. Filip. (2014) Metformin associated with photodynamic therapy – A novel oncological direction. Journal of Photochemistry and Photobiology B: Biology 138, pages 80-91.
Crossref
Crossref
James A. McCubrey, Nicole M. Davis, Stephen L. Abrams, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Ferdinando Nicoletti, Antonino B. D'Assoro, Lucio Cocco, Alberto M. Martelli & Linda S. Steelman. (2014) Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. Advances in Biological Regulation 56, pages 81-107.
Crossref
Crossref
Jing Zhang, Chengwu Shen, Lin Wang, Quanping Ma, Pingtian Xia, Mei Qi, Muyi Yang & Bo Han. (2014) Metformin inhibits epithelial–mesenchymal transition in prostate cancer cells: Involvement of the tumor suppressor miR30a and its target gene SOX4. Biochemical and Biophysical Research Communications 452:3, pages 746-752.
Crossref
Crossref
B Auffinger, A L Tobias, Y Han, G Lee, D Guo, M Dey, M S Lesniak & A U Ahmed. (2014) Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy. Cell Death & Differentiation 21:7, pages 1119-1131.
Crossref
Crossref
Soichiro Honjo, Jaffer Ajani, Ailing Scott, Qiongrong Chen, Heath Skinner, John Stroehlein, Randy Johnson & Shumei Song. (2014) Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer. International Journal of Oncology.
Crossref
Crossref
Li Li, Rui Han, Hualiang Xiao, Caiyu Lin, Yubo Wang, Hao Liu, Kunlin Li, Hengyi Chen, Fenfen Sun, Zhenzhou Yang, Jianxin Jiang & Yong He. (2014)
Metformin Sensitizes EGFR-TKI–Resistant Human Lung Cancer Cells
In Vitro
and
In Vivo
through Inhibition of IL-6 Signaling and EMT Reversal
. Clinical Cancer Research 20:10, pages 2714-2726.
Crossref
Crossref
Alastair M. Thompson. (2014) Molecular Pathways: Preclinical Models and Clinical Trials with Metformin in Breast Cancer. Clinical Cancer Research 20:10, pages 2508-2515.
Crossref
Crossref
Fatima Ismail & David A. Winkler. (2014) Getting to the Source: Selective Drug Targeting of Cancer Stem Cells. ChemMedChem 9:5, pages 885-898.
Crossref
Crossref
Zhongquan Zhao, Xiaoming Cheng, Yubo Wang, Rui Han, Li Li, Tong Xiang, Luhang He, Haixia Long, Bo Zhu & Yong He. (2014) Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis. PLoS ONE 9:4, pages e95884.
Crossref
Crossref
Aleksandra Markiewicz, Magdalena Ksi??kiewicz, Marzena We?nicka-Ja?kiewicz, Barbara Seroczy?ska, Jaros?aw Skokowski, Jolanta Szade & Anna J. ?aczek. (2014) Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential. PLoS ONE 9:4, pages e93901.
Crossref
Crossref
A. Bhangu, G. Wood, G. Brown, A. Darzi, P. Tekkis & R. Goldin. (2014) The role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancer. Colorectal Disease 16:4, pages O133-O143.
Crossref
Crossref
Mark F. McCarty. (2013) AMPK activation—protean potential for boosting healthspan. AGE 36:2, pages 641-663.
Crossref
Crossref
Pei Zhu, Meghan Davis, Amanda J. Blackwelder, Nora Bachman, Bolin Liu, Susan Edgerton, Leonard L. Williams, Ann D. Thor & Xiaohe Yang. (2014) Metformin Selectively Targets Tumor-Initiating Cells in ErbB2-Overexpressing Breast Cancer Models. Cancer Prevention Research 7:2, pages 199-210.
Crossref
Crossref
Emanuela Paldino, Valentina Tesori, Patrizia Casalbore, Antonio Gasbarrini & Maria Ausiliatrice Puglisi. (2014) Tumor Initiating Cells and Chemoresistance: Which Is the Best Strategy to Target Colon Cancer Stem Cells?. BioMed Research International 2014, pages 1-7.
Crossref
Crossref
Wanxing Duan, Xin Shen, Jianjun Lei, Qinhong Xu, Yongtian Yu, Rong Li, Erxi Wu & Qingyong Ma. (2014) Hyperglycemia, a Neglected Factor during Cancer Progression. BioMed Research International 2014, pages 1-10.
Crossref
Crossref
Yujie Liu, Haiyan Li, Juan Feng, Xiuying Cui, Wei Huang, Yudong Li, Fengxi Su, Qiang Liu, Jiujun Zhu, Xiaobin Lv, Jianing Chen, Di Huang & Fengyan Yu. (2013) Lin28 Induces Epithelial-to-Mesenchymal Transition and Stemness via Downregulation of Let-7a in Breast Cancer Cells. PLoS ONE 8:12, pages e83083.
Crossref
Crossref
Poulomi BanerjeeRamesh R. BhondeRajarshi Pal. (2013) Diverse Roles of Metformin During Peri-Implantation Development: Revisiting Novel Molecular Mechanisms Underlying Clinical Implications. Stem Cells and Development 22:22, pages 2927-2934.
Crossref
Crossref
Yeon Kyung Choi & Keun-Gyu Park. (2013) Metabolic roles of AMPK and metformin in cancer cells. Molecules and Cells 36:4, pages 279-287.
Crossref
Crossref
Pengpeng Zhang, Hao Li, Xianhua Tan, Lili Chen & Shumei Wang. (2013) Association of metformin use with cancer incidence and mortality: A meta-analysis. Cancer Epidemiology 37:3, pages 207-218.
Crossref
Crossref
M A Pierotti, F Berrino, M Gariboldi, C Melani, A Mogavero, T Negri, P Pasanisi & S Pilotti. (2012) Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects. Oncogene 32:12, pages 1475-1487.
Crossref
Crossref
Cord Naujokat & Stefan Laufer. 2013. Role of Cancer Stem Cells in Cancer Biology and Therapy. Role of Cancer Stem Cells in Cancer Biology and Therapy
227
256
.
Hyeong Kyu Park. (2013) Metformin and Cancer in Type 2 Diabetes. Diabetes & Metabolism Journal 37:2, pages 113.
Crossref
Crossref
Reza Shirkoohi. (2012) Epithelial mesenchymal transition from a natural gestational orchestration to a bizarre cancer disturbance. Cancer Science 104:1, pages 28-35.
Crossref
Crossref
Miyuki Shimoda, Tsuyoshi Sugiura, Ikumi Imajyo, Kotaro Ishii, Satomi Chigita, Katsuhiro Seki, Yousuke Kobayashi & Kanemitsu Shirasuna. (2012) The T-box transcription factor Brachyury regulates epithelial–mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells. BMC Cancer 12:1.
Crossref
Crossref
Guislaine Barrière, Alain Riouallon, Joël Renaudie, Michel Tartary & Michel Rigaud. (2012) Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis. BMC Cancer 12:1.
Crossref
Crossref
Aneel Bhangu, Gemma Wood, Alex Mirnezami, Ara Darzi, Paris Tekkis & Robert Goldin. (2012) Epithelial mesenchymal transition in colorectal cancer: Seminal role in promoting disease progression and resistance to neoadjuvant therapy. Surgical Oncology 21:4, pages 316-323.
Crossref
Crossref
Jun Xia, Changjie Chen, Zhiwen Chen, Lucio Miele, Fazlul H. Sarkar & Zhiwei Wang. (2012) Targeting pancreatic cancer stem cells for cancer therapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1826:2, pages 385-399.
Crossref
Crossref
Jessica J. Shank, Kun Yang, Jacob Ghannam, Lourdes Cabrera, Carolyn J. Johnston, R. Kevin Reynolds & Ronald J. Buckanovich. (2012) Metformin targets ovarian cancer stem cells in vitro and in vivo. Gynecologic Oncology 127:2, pages 390-397.
Crossref
Crossref
Philip L. Leopold, Jan Vincent & Hongjun Wang. (2012) A comparison of epithelial-to-mesenchymal transition and re-epithelialization. Seminars in Cancer Biology 22:5-6, pages 471-483.
Crossref
Crossref
Taxiarchis V. Kourelis & Robert D. Siegel. (2011) Metformin and cancer: new applications for an old drug. Medical Oncology 29:2, pages 1314-1327.
Crossref
Crossref
Mingli Han, Manran Liu, Yimeng Wang, Zhiqiang Mo, Xiaokai Bi, Zhirong Liu, Yuanming Fan, Xin Chen & Chengyi Wu. (2011) Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells. Molecular and Cellular Biochemistry 363:1-2, pages 427-436.
Crossref
Crossref
Bin Bao, Zhiwei Wang, Shadan Ali, Aamir Ahmad, Asfar S. Azmi, Sanila H. Sarkar, Sanjeev Banerjee, Dejuan Kong, Yiwei Li, Shivam Thakur & Fazlul H. Sarkar. (2012) Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells. Cancer Prevention Research 5:3, pages 355-364.
Crossref
Crossref
Seth B. Krantz, Mario A. Shields, Surabhi Dangi-Garimella, Hidayatullah G. Munshi & David J. Bentrem. (2012) Contribution of Epithelial-to-Mesenchymal Transition and Cancer Stem Cells to Pancreatic Cancer Progression. Journal of Surgical Research 173:1, pages 105-112.
Crossref
Crossref
Alejandro Vazquez-MartinSalvador Fernández-ArroyoSílvia CufíCristina Oliveras-FerrarosJesús Lozano-SánchezLuciano VellónVicente MicolJorge JovenAntonio Segura-CarreteroJavier A. Menendez. (2012) Phenolic Secoiridoids in Extra Virgin Olive Oil Impede Fibrogenic and Oncogenic Epithelial-to-Mesenchymal Transition: Extra Virgin Olive Oil As a Source of Novel Antiaging Phytochemicals. Rejuvenation Research 15:1, pages 3-21.
Crossref
Crossref
Mark F. McCarty. (2012) Metformin may antagonize Lin28 and/or Lin28B activity, thereby boosting let-7 levels and antagonizing cancer progression. Medical Hypotheses 78:2, pages 262-269.
Crossref
Crossref
Guislaine Barrière, Michel Tartary & Michel Rigaud. (2012) Epithelial Mesenchymal Transition: A New Insight into the Detection of Circulating Tumor Cells. ISRN Oncology 2012, pages 1-6.
Crossref
Crossref
. (2012) Current World Literature. Current Opinion in Oncology 24:1, pages 109-114.
Crossref
Crossref
Ahmad Aljada & Shaker A. Mousa. (2012) Metformin and neoplasia: Implications and indications. Pharmacology & Therapeutics 133:1, pages 108-115.
Crossref
Crossref
P. And?jar-Plata, X. Pi-Sunyer & B. Laferr?re. (2012) Metformin effects revisited. Diabetes Research and Clinical Practice 95:1, pages 1-9.
Crossref
Crossref
Ryan JO Dowling, Pamela J Goodwin & Vuk Stambolic. (2011) Understanding the benefit of metformin use in cancer treatment. BMC Medicine 9:1.
Crossref
Crossref
Emily Jane Gallagher & Derek LeRoith. (2011) Diabetes, cancer, and metformin: connections of metabolism and cell proliferation. Annals of the New York Academy of Sciences 1243:1, pages 54-68.
Crossref
Crossref
Alejandro Vazquez-Martin, Eugeni López-Bonetc, Sílvia Cufí, Cristina Oliveras-Ferraros, Sonia Del Barco, Begoña Martin-Castillo & Javier A. Menendez. (2011) Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions. Drug Resistance Updates 14:4-5, pages 212-223.
Crossref
Crossref
Yan LI, Xiao-Yu WANG, Li-Jing WANG, Tao XU, Xiao-Ye LU, Dong-Qing CAI, Jian-Guo GENG & Xue-Song YANG. (2011) <I>PTEN</I> impedes EMT during chick embryo gastrulation. Hereditas (Beijing) 33:6, pages 613-619.
Crossref
Crossref
Masaya Takehara, Tatsuya Hoshino, Takushi Namba, Naoki Yamakawa & Tohru Mizushima. (2011) Acetaminophen-induced differentiation of human breast cancer stem cells and inhibition of tumor xenograft growth in mice. Biochemical Pharmacology 81:9, pages 1124-1135.
Crossref
Crossref
Ryou-u Takahashi, Fumitaka Takeshita, Tomohiro Fujiwara, Makiko Ono & Takahiro Ochiya. (2011) Cancer Stem Cells in Breast Cancer. Cancers 3:1, pages 1311-1328.
Crossref
Crossref
Rosamaria Lappano & Marcello Maggiolini. (2010) G protein-coupled receptors: novel targets for drug discovery in cancer. Nature Reviews Drug Discovery 10:1, pages 47-60.
Crossref
Crossref
Seth B. Krantz, Mario A. Shields, Surabhi Dangi-Garimella, David J. Bentrem & Hidayatullah G. Munshi. (2010) Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression. Cancers 2:4, pages 2084-2097.
Crossref
Crossref